Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 16 January 1987:
Vol. 235. no. 4786, pp. 321 - 324
DOI: 10.1126/science.3492043

Articles

Science, Vol 235, Issue 4786, 321-324
Copyright © 1987 by American Association for the Advancement of Science


articles

Construction of a novel oncogene based on synthetic sequences encoding epidermal growth factor

DF Stern, DL Hare, MA Cecchini, and RA Weinberg

The autocrine model postulates that constitutive release of a mitogenic growth factor can lead to uncontrolled proliferation and cell transformation. A synthetic polynucleotide encoding epidermal growth factor conferred a tumorigenic phenotype on cells. These cells were transformed through the action of an autocrine circuit having an extracellular component.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Epidermal Growth Factor Gene Functional Polymorphism and the Risk of Hepatocellular Carcinoma in Patients With Cirrhosis.
K. K. Tanabe, A. Lemoine, D. M. Finkelstein, H. Kawasaki, T. Fujii, R. T. Chung, G. Y. Lauwers, Y. Kulu, A. Muzikansky, D. Kuruppu, et al. (2008)
JAMA 299, 53-60
   Abstract »    Full Text »    PDF »
Retroviral vectors preloaded with a viral receptor-ligand bridge protein are targeted to specific cell types.
A. L. Boerger, S. Snitkovsky, and J. A. T. Young (1999)
PNAS 96, 9867-9872
   Abstract »    Full Text »    PDF »
Heparin-binding epidermal growth factor-like growth factor, a v-Jun target gene, induces oncogenic transformation.
S.-l. Fu, I. Bottoli, M. Goller, and P. K. Vogt (1999)
PNAS 96, 5716-5721
   Abstract »    Full Text »    PDF »
Cell-specific viral targeting mediated by a soluble retroviral receptor-ligand fusion protein.
S. Snitkovsky and J. A. T. Young (1998)
PNAS 95, 7063-7068
   Abstract »    Full Text »    PDF »
Interactions within the Yeast Sm Core Complex: from Proteins to Amino Acids.
A. Camasses, E. Bragado-Nilsson, R. Martin, B. Séraphin, and R. Bordonné (1998)
Mol. Cell. Biol. 18, 1956-1966
   Abstract »    Full Text »
Evidence for the Participation of Interleukin-2 (IL-2) and IL-4 in the Regulation of Autonomous Growth and Tumorigenesis of Transformed Cells of Lymphoid Origin.
M. R. Hassuneh, P. S. Nagarkatti, and M. Nagarkatti (1997)
Blood 89, 610-620
   Abstract »    Full Text »    PDF »
Rapid induction of heparin-binding epidermal growth factor/diphtheria toxin receptor expression by Raf and Ras oncogenes..
S A McCarthy, M L Samuels, C A Pritchard, J A Abraham, and M McMahon (1995)
Genes & Dev. 9, 1953-1964
   Abstract »    PDF »
The Role of Phosphotyrosine Signaling Pathway in Parotid Gland Proliferation and Function.
K.R. Purushotham and M.G. Humphreys-Beher (1995)
Critical Reviews in Oral Biology & Medicine 6, 119-131
   Abstract »    Full Text »    PDF »
A specific inhibitor of the epidermal growth factor receptor tyrosine kinase.
D. Fry, A. Kraker, A McMichael, L. Ambroso, J. Nelson, W. Leopold, R. Connors, and A. Bridges (1994)
Science 265, 1093-1095
   Abstract »    PDF »
Role of Intrinsic Protein Tyrosine Kinase in Function and Metabolism of the Epidermal Growth Factor Receptor.
G.N. Gill, W.S. Chen, C.S. Lazar, J.R. Glenney Jr., H.S. Wiley, H.A. Ingraham, and M.G. Rosenfeld (1988)
Cold Spring Harb Symp Quant Biol 53, 467-476
   Abstract »    PDF »
Influence of p21ras on Phosphatidylinositol Turnover.
J. Downward and R.A. Weinberg (1988)
Cold Spring Harb Symp Quant Biol 53, 883-892
   Abstract »    PDF »
Epidermal-growth-factor-dependent transformation by a human EGF receptor proto-oncogene.
T. Velu, L Beguinot, W. Vass, M. Willingham, G. Merlino, I Pastan, and D. Lowy (1987)
Science 238, 1408-1410
   Abstract »    PDF »



To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)